Signaturefd LLC Has $53,000 Stock Position in Alignment Healthcare, Inc. $ALHC

Signaturefd LLC grew its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 142.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,768 shares of the company’s stock after buying an additional 2,215 shares during the quarter. Signaturefd LLC’s holdings in Alignment Healthcare were worth $53,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. MCF Advisors LLC grew its holdings in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after buying an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Alignment Healthcare during the first quarter valued at about $42,000. Amalgamated Bank grew its holdings in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock valued at $65,000 after buying an additional 616 shares during the last quarter. Ballentine Partners LLC grew its holdings in shares of Alignment Healthcare by 10.2% during the second quarter. Ballentine Partners LLC now owns 12,862 shares of the company’s stock valued at $180,000 after buying an additional 1,188 shares during the last quarter. Finally, Regal Partners Ltd acquired a new position in shares of Alignment Healthcare during the first quarter valued at about $194,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Alignment Healthcare news, President Dawn Christine Maroney sold 215,662 shares of Alignment Healthcare stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the sale, the president owned 1,797,237 shares of the company’s stock, valued at approximately $29,492,659.17. The trade was a 10.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Christopher J. Joyce sold 30,939 shares of the business’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $507,708.99. Following the completion of the sale, the insider directly owned 343,592 shares in the company, valued at approximately $5,638,344.72. This trade represents a 8.26% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,388,173 shares of company stock valued at $118,068,256. Company insiders own 6.60% of the company’s stock.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $17.11 on Tuesday. The firm has a market cap of $3.39 billion, a price-to-earnings ratio of -61.10 and a beta of 1.18. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. Alignment Healthcare, Inc. has a 52 week low of $10.11 and a 52 week high of $21.06. The firm’s 50-day simple moving average is $15.70 and its two-hundred day simple moving average is $15.65.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company’s revenue for the quarter was up 49.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Saturday, September 27th. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target on the stock in a research report on Monday, August 25th. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 29th. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, August 10th. Finally, Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.